Glucose Health (OTCMKTS:GLUC – Get Free Report) announced its earnings results on Monday. The company reported ($0.01) earnings per share (EPS) for the quarter, Zacks reports. The business had revenue of $0.05 million for the quarter.
Glucose Health Stock Performance
GLUC remained flat at $0.30 on Wednesday. 27,300 shares of the company traded hands, compared to its average volume of 18,329. The stock’s 50 day simple moving average is $0.36 and its 200 day simple moving average is $0.36. Glucose Health has a 52 week low of $0.13 and a 52 week high of $0.67. The stock has a market cap of $8.54 million, a price-to-earnings ratio of -10.00 and a beta of 1.30.
Recent Glucose Health Headlines
Investors following GLUC have been watching these headlines:
- Neutral Sentiment: Several articles discuss blood-sugar-friendly foods, diabetes awareness and care, and people’s control over diabetes-related health data. These are broad health stories and do not describe a GLUC product, partnership, or change in demand. International charter urges greater control over diabetes health data Breakfast swaps to curb blood sugar crashes
- Negative Sentiment: Glucose Health reported earnings per share of -$0.01 and quarterly revenue of just $0.05 million. The results indicate a loss and very limited reported sales; the provided information does not include year-over-year comparisons or guidance to show whether performance improved or worsened. Glucose Health company and earnings information
About Glucose Health
Glucose Health, Inc. is a consumer health company focused on nutritional products designed to support healthy blood sugar levels. Its principal product is Glucose Health® Blood Sugar Support Drink Mix, a powdered beverage marketed for people seeking a convenient addition to their daily wellness routine. The company’s product is positioned as nutritional support, not as a treatment for diabetes or other medical conditions.
Featured Articles
- Five stocks we like better than Glucose Health
- Palantir’s Political Controversy Is Hiding a Much Bigger Story
- General Motors Faces a Cost Squeeze as Factory Automation Takes Center Stage
- 5 Consumer Discretionary Plays Showing Strength During the Tech Sell-Off
- NVIDIA’s Earnings Were Strong, But Can the Next CEO Keep the Momentum Going?
Receive News & Ratings for Glucose Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Glucose Health and related companies with MarketBeat.com's FREE daily email newsletter.
